Latest Period
Q4 2025
Security Snapshot
Lyra Therapeutics, Inc. - Common Stock (LYRA) Institutional Ownership
CUSIP: 55234L204
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
22
Shares (Excl. Options)
242,614
Price
$3.08
Save this security research path
Keep this CUSIP in your research flow, then return after the next filing cycle to check what changed.
- Type / Class
- Equity / Common Stock
- Symbol
- LYRA on OTC
- Shares outstanding
- 1,769,273
- Price per share
- $1.34
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 242,614
- Total reported value
- $747,316
- % of total 13F portfolios
- 0%
- Share change
- -205,974
- Value change
- -$1,598,144
- Number of holders
- 22
- Price from insider filings
- $1.34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- LYRA - Lyra Therapeutics, Inc. - Common Stock is tracked under CUSIP 55234L204.
- 22 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 22 to 0 between Q4 2025 and Q1 2026.
- Reported value moved from $747,316 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 55234L204?
CUSIP 55234L204 identifies LYRA - Lyra Therapeutics, Inc. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 55234L204:
Significant Owners of Lyra Therapeutics, Inc. - Common Stock (LYRA) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 9.9% | $628,817 | 175,158 | SABBY MANAGEMENT, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 22 institutional investors reported holding 242,614 shares of Lyra Therapeutics, Inc. - Common Stock (LYRA). This represents 14% of the company’s total 1,769,273 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Lyra Therapeutics, Inc. - Common Stock (LYRA) together control 14% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 9.9% | 175,158 | +37% | 4.5% | $539,487 |
| Ikarian Capital, LLC | 1.2% | 21,161 | 0% | 0.01% | $65,176 |
| DRW Securities, LLC | 0.95% | 16,812 | 0% | $51,780 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.69% | 12,249 | +11% | 0% | $37,733 |
| Artia Global Partners LP | 0.49% | 8,756 | 0% | $26,968 | |
| BlackRock, Inc. | 0.14% | 2,394 | +42% | 0% | $7,373 |
| Tower Research Capital LLC (TRC) | 0.12% | 2,191 | +310% | 0% | $6,748 |
| ROYAL BANK OF CANADA | 0.11% | 1,928 | +46% | 0% | $6,000 |
| UBS Group AG | 0.04% | 675 | -83% | 0% | $2,079 |
| EverSource Wealth Advisors, LLC | 0.02% | 338 | -2% | 0% | $1,041 |
| MORGAN STANLEY | 0.02% | 334 | -74% | 0% | $1,029 |
| JONES FINANCIAL COMPANIES LLLP | 0.01% | 210 | 0% | 0% | $647 |
| BANK OF AMERICA CORP /DE/ | 0.01% | 201 | +1017% | 0% | $619 |
| SBI Securities Co., Ltd. | 0% | 80 | 0% | 0% | $246 |
| JPMORGAN CHASE & CO | 0% | 27 | 0% | 0% | $83 |
| COMERICA BANK | 0% | 23 | 0% | 0% | $71 |
| OSAIC HOLDINGS, INC. | 0% | 22 | 0% | 0% | $67 |
| Wilmington Savings Fund Society, FSB | 0% | 20 | 0% | 0% | $62 |
| BNP PARIBAS FINANCIAL MARKETS | 0% | 16 | 0% | 0% | $49 |
| Global Retirement Partners, LLC | 0% | 15 | 0% | $46 | |
| CITIGROUP INC | 0% | 3 | -100% | 0% | $9 |
| IFP Advisors, Inc | 0% | 1 | -50% | 0% | $3 |
| CITADEL ADVISORS LLC | 0% | 0 | -100% | $0 | |
| Signature Resources Capital Management, LLC | 0% | 0 | -100% | $0 | |
| VANGUARD GROUP INC | 0% | 0 | -100% | $0 |